Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

NCT06070961 · clinicaltrials.gov ↗

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DIAGNOSTIC_TEST: Cellular immunity vs SARS-CoV-2
DIAGNOSTIC_TEST: Humoral immunity vs SARS-CoV-2
DIAGNOSTIC_TEST: Cellular immunity vs Varicella Zoster Virus
DIAGNOSTIC_TEST: Humoral immunity vs Varicella Zoster Virus
DIAGNOSTIC_TEST: Diphtheria toxin-binding IgG
DIAGNOSTIC_TEST: Tetanus toxoid-binding IgG
DIAGNOSTIC_TEST: T-cell populations and markers characterization

Sponsor

Fondazione Italiana Linfomi - ETS